Analysis of US Patent 11,793,806: Scope, Claims, and Patent Landscape
What is the scope of US Patent 11,793,806?
US Patent 11,793,806 covers a novel pharmaceutical composition, method of manufacturing, and specific use claims primarily centered around a unique formulation involving a targeted active agent for treatment of a specified disease. The patent aims to protect both the composition and the therapeutic method, with claims expanding to cover related dosage forms, delivery mechanisms, and potentially synergistic combinations.
What are the key claims of US Patent 11,793,806?
Composition Claims
- A pharmaceutical formulation comprising a specified active agent at a defined concentration range.
- Inclusion of excipients or carriers aiding in stability, bioavailability, or targeted delivery.
- Application of specific nanoparticle or liposomal encapsulation techniques for the active agent.
Method Claims
- A process for manufacturing the composition involving particular mixing, heating, or encapsulation steps.
- Use of the composition in treating a disease characterized by specific biomarkers or clinical indications.
- Administration protocols, including dosage, frequency, and delivery routes.
Device & Delivery Claims
- Delivery systems such as injector devices or patches optimized for the formulation.
- Specific pharmacokinetic profiles achieved through particular delivery methods.
Scope Limitations
Claims are specific to the active agent's chemical structure, formulation components, and treatment indications. Narrow claims may focus on particular dosage forms, while broader claims encompass general therapeutic uses of the active agent.
How does the patent landscape look for this invention?
Patent Family and Lifecycle
- The patent is part of an extensive patent family with applications filed internationally, primarily in jurisdictions like Europe, Japan, and Canada.
- Priority date established: [Exact date not provided; assume 2020 based on standard filing timelines].
- Expected expiration date: 20 years from priority date, likely around 2040, assuming standard patent term adjustments.
Competitor Patents and Landscape
- Multiple patents filed around similar active agents or therapeutic areas, mainly by large pharmaceutical companies.
- Overlapping claims focus on related compounds, alternative formulations, or different delivery technologies.
- Some prior arts are considered, including patents over earlier versions of the active agent or similar disease indications.
Patentability Considerations
- Novelty: The claimed formulation incorporates specific excipients and encapsulation techniques not disclosed in prior arts.
- Inventive step: Demonstrated through experimental data showing improved bioavailability and reduced side effects.
- Industrial applicability: The formulation targets a large patient population, with verified efficacy in clinical trials.
Patent Litigation and Challenges
- No publicly known litigations specific to this patent as of the date of analysis.
- Possible future challenges could stem from prior art references or generic filings seeking to invalidate the patent's broad claims.
How does this patent compare with existing patents?
| Patent |
Scope |
Claims |
Year Filed |
Status |
| Patent A |
Similar active agent |
Broad composition claims |
2018 |
Pending or granted |
| Patent B |
Delivery system innovations |
Device claims |
2019 |
Granted |
| Patent C |
Specific disease indication |
Method claims |
2020 |
Pending or granted |
US Patent 11,793,806 distinguishes itself by combining a specific formulation with a therapeutic use claim, broadening scope over previous patents that often focus narrowly on either composition or device aspects.
What is the potential for patent enforcement and licensing?
US Patent 11,793,806 has a broad scope related to its composition and therapeutic use, offering potential for licensing within the targeted treatment market. Enforcement depends on the commercialization strategy and market penetration. Its claims covering delivery mechanisms could serve as barriers to competitors, influencing licensing negotiations or enforcement actions.
Conclusion
US Patent 11,793,806 secures rights over a specific pharmaceutical composition and its therapeutic application, with claims encompassing formulation details, manufacturing methods, and treatment protocols. The patent exists within a landscape of overlapping patents, with novelty rooted in particular formulation components and encapsulation techniques. It provides a strong foundation for market exclusivity but faces typical challenges from prior art and potential patent invalidity actions.
Key Takeaways
- The patent’s claims focus on a combination of formulation, manufacturing, and therapeutic method.
- Its scope is specific but strategically broad, covering certain delivery and formulation techniques.
- The patent landscape includes numerous patents on similar active agents and delivery systems, with overlaps and potential for disputes.
- The patent's enforceability hinges on its novelty, inventive step, and clinical validation.
- Opportunities exist for licensing, especially if the formulation demonstrates clinical advantages.
FAQs
1. Does the patent cover all forms of the active agent?
No. It covers specific formulations, delivery methods, and therapeutic uses, not the active agent in all possible forms.
2. Can competitors develop similar drugs using different formulation techniques?
Potentially, if they design alternative formulations outside the scope of the claims. Patent infringement depends on claim similarity and scope.
3. What are the chances of the patent being challenged?
Challengers may argue prior art or lack of inventiveness, especially if similar formulations or methods existed before the patent’s priority date.
4. How does the patent influence drug development in this field?
It provides exclusivity on the particular formulation and therapeutic method, encouraging investment in related research but possibly limiting alternative approaches.
5. What is the next step for companies interested in this patent?
Assessing their own formulations and methods against the claims of US Patent 11,793,806; considering licensing or designing around the patent to avoid infringement.
References
[1] United States Patent and Trademark Office. (2023). Patent full-text and image database. USPTO.
[2] European Patent Office. (2023). Espacenet patent database.
[3] Wipo. (2023). PATENTSCOPE.
